Media Coverage
"ALung Technologies, Inc., a Pittsburgh-based company in the respiratory health field, reached record enrollment numbers for a clinical trial of its artificial lung techn...
Suffering from cystic fibrosis and rejecting the transplanted lungs he had gotten just two years ago, Jon Sacker, 33, came to UPMC in Pittsburgh from his hometown in Moore, Oklahoma, as a last resort...
We are honored to have the Hemolung RAS recognized as a finalist for the 2014 MDEA Awards. This admission is the result of more than 10 years of dedication and persever...
Press Releases
PITTSBURGH – December 10, 2018 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patien...
The UK-based REST Trial of the Hemolung RAS is now the world’s largest trial of extracorporeal lung support. PITTSBURGH – September 4, 2018 – ALung Technologies, Inc...
PITTSBURGH (February 27, 2018) - ALung Technologies, Inc., today announced that it has initiated patient enrollment in its VENT-AVOID Trial of the Hemolung RAS. The M...